US Patent 7524873 Calcium receptor modulating agents
Patent 7524873 was granted and assigned to Amgen on April, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+96 characters)
Article
Patent abstract
The compounds of the invention are represented by the following general structure
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07524873 Calcium receptor modulating agents US Patent 7524873 Calcium receptor modulating agents
Infobox
Patent Number
0752487300
Patent Number
752487300
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075248730
Date of Patent
April 28, 2009
0Patent Application Number
117003360
Date Filed
January 30, 2007
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075248730
Date of Patent
April 28, 2009
0Patent Application Number
117003360
Date Filed
January 30, 2007
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07524873 Calcium receptor modulating agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07524873
Date of patent
April 28, 2009
Patent application number
11700336
Date Filed
January 30, 2007
Patent primary examiner
Find more entities like US Patent 7524873 Calcium receptor modulating agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
